Caption Management’s Biohaven BHVN Stock Holding History

Caption Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Sell	335,000 -966,000	-74%	-$10.6M	0.02%	716
2025 Q4	$14.7M	Buy	1,301,000 +532,200	+69%	+$6.59M	0.1%	243
2025 Q3	$11.5M	Sell	768,800 -171,300	-18%	-$2.49M	0.09%	241
2025 Q2	$13.3M	Buy	940,100 +840,100	+840%	+$15M	0.15%	150
2025 Q1	$2.4M	Buy	100,000 +25,000	+33%	+$882K	0.02%	632
2024 Q4	$2.8M	Sell	75,000 -47,400	-39%	-$2.21M	0.03%	576
2024 Q3	$6.12M	Buy	122,400 +82,400	+206%	+$3.21M	0.1%	248
2024 Q2	$1.39M	Sell	40,000 -100,000	-71%	-$3.95M	0.02%	570
2024 Q1	$7.66M	Buy	140,000 +115,000	+460%	+$5.69M	0.12%	219
2023 Q4	$1.07M	Sell	25,000 -15,000	-38%	-$466K	0.01%	785
2023 Q3	$1.04M	Sell	40,000 -60,000	-60%	-$1.25M	0.02%	768
2023 Q2	$2.39M	Buy	+100,000	New	+$1.72M	0.04%	451

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's BHVN Position: Q1 2026 in Review

Caption Management opened a new position in Biohaven (BHVN) in Q1 2026: 75,339 shares worth $637K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: Caption Management previously reported a position in BHVN as recently as Q3 2025.

Caption Management first reported a position in BHVN in Q4 2023 and has held it in 7 quarters since. The position peaked at $9.42M in Q3 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Caption Management held 75,339 shares of Biohaven worth $637K as of Q1 2026.
Biohaven was a new Caption Management position in Q1 2026.
Biohaven made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1148 holding.
Caption Management first reported a position in Biohaven in Q4 2023 and has held it in 7 quarters since.
Caption Management's Biohaven position peaked at $9.42M in Q3 2025.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.